🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the present study is to evaluate if addition of methotrexate ca...
Status
Completed
Location
The E. Wolfson.Medical Center
Start Date
2015-07
Trial ID
NCT02269358
Treatments Being Tested
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
This study investigates the activity of a new regimen of treatment for pati...
Status
Completed
Location
Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus,
Start Date
2015-01
Trial ID
NCT02280694
Treatments Being Tested
To evaluate the outcome of a prednisolone and low dose methotrexate based p...
Status
Active Not Recruiting
Location
Prince of Wales Hospital
Start Date
2017-04-18
Trial ID
NCT03286634
The purpose of this study is to assess the potential for pegloticase with m...
Status
Completed
Location
University of Alabama
Start Date
2019-06-13
Trial ID
NCT03994731
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Status
Completed
Location
HealthOne Presbyterian St. Lukes Medical Center
Start Date
2006-01
Trial ID
NCT00322101
Treatments Being Tested
This study will be conducted in different centres and will study adult pati...
Status
Completed
Location
S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Start Date
2014-05-20
Trial ID
NCT02067143
In the treatment of Ph-negative (Ph-) B-cell acute lymphoblastic leukemia (...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2024-04-02
Trial ID
NCT06387121
This is a multicenter, Phase II, randomized, double-blind, placebo-controll...
Status
Completed
Location
Pinnacle Research Group; Llc, Central
Start Date
2016-09-09
Trial ID
NCT02833350
Treatments Being Tested